Sensei Biotherapeutics, Inc.
SNSE
$10.33
$2.8538.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.11% | -4.80% | -1.81% | 23.91% | 21.47% |
| Total Depreciation and Amortization | -89.73% | 0.61% | 0.00% | -1.20% | -7.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -59.58% | 5.67% | -26.39% | -28.25% | 15.27% |
| Change in Net Operating Assets | 39.80% | 162.50% | -38.41% | 104.96% | 55.32% |
| Cash from Operations | 6.85% | 6.02% | -17.36% | 38.79% | 35.11% |
| Capital Expenditure | -- | -- | -- | -275.86% | 75.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.14% | -138.14% | 55.37% | -63.83% | 136.63% |
| Cash from Investing | 24.63% | -138.14% | 55.37% | -64.63% | 149.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.03% | -5.61% | -7.37% | -6.35% | -6.99% |
| Issuance of Common Stock | -- | -23.53% | -- | -32.26% | -- |
| Repurchase of Common Stock | 70.00% | 100.00% | 100.00% | 100.00% | 86.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.39% | 54.99% | 91.95% | 97.73% | 20.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.31% | -647.78% | 548.16% | -55.83% | 78.78% |